Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study

The feasibility of combining UFT plus leucovorin (LV) with alternating irinotecan and oxaliplatin was investigated in the first-line treatment of patients with advanced colorectal cancer. Twenty-five patients, median age 63 (range 24–79) years, World Health Organisation performance status 0–2 and me...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, H Y, Valle, J W, Palmer, K, Sjursen, A, Craven, O, Wilson, G, Swindell, R, Saunders, M P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360216/
https://www.ncbi.nlm.nih.gov/pubmed/17213824
http://dx.doi.org/10.1038/sj.bjc.6603521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360216/
https://www.ncbi.nlm.nih.gov/pubmed/17213824
http://dx.doi.org/10.1038/sj.bjc.6603521

Ejemplares similares